TABLE 1.
Antibiotic group | Definition | No. (%) |
---|---|---|
Clindamycin | IV or oral clindamycin | 385 (31) |
MSSA coverage | Nafcillin, oxacillin, cefazolin, cephalexin, IV or oral cephradine | 22 (2) |
MRSA coverage | IV vancomycin, IV or oral linezolid, IV or oral doxycycline, IV or oral trimethoprim/sulfamethoxazole, daptomycin | 7 (1) |
Clindamycin plus MSSA coverage | IV or oral clindamycin plus ≥1 of the MSSA group | 274 (22) |
Clindamycin plus MRSA coverage | IV or oral clindamycin plus ≥1 of the MRSA group | 169 (14) |
Clindamycin plus MSSA plus MRSA coverage | IV or oral clindamycin plus MSSA and MRSA coverage | 76 (6) |
MSSA plus MRSA coverage | MSSA plus MRSA coverage | 31 (3) |
Broad spectrum | Vancomycin, nafcillin, oxacillin, cefazolin AND/OR clindamycin plus ≥1 of the following: ceftriaxone, cefepime, cefotaxime, piperacillin-tazobactam, gentamicin, or meropenem | 203 (16) |
Other | Any other antibiotic or combination that did not fit into the above groups | 80 (6) |
Abbreviations: IV, intravenous; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.